{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Salem Erode Investments Ltd
Salem Erode Investments Q2 FY26: Mounting Losses Signal Deepening Distress
Salem Erode Investments Ltd., a micro-cap non-banking financial company with a market capitalisation of ₹47.00 crores, reported another dismal quarter in Q2 FY26, posting a net loss of ₹1.20 crores—a sequential deterioration of 21.21% from Q1 FY26's loss of ₹0.99 crores and a staggering 41.18% worse year-on-year compared to Q2 FY25's loss of ₹0.85 crores. The company's struggles intensified as revenue contracted sharply by 18.35% quarter-on-quarter to ₹0.89 crores, whilst employee costs remained stubbornly elevated at ₹0.90 crores, exceeding total income and pushing operating margins deep into negative territory at -57.30%.
How has been the historical performance of Salem Erode Inv.?
Salem Erode Inv. has experienced declining financial performance, with net sales decreasing from 4.09 Cr in March 2024 to 3.85 Cr in March 2025, and significant operating losses worsening to -3.38 Cr in March 2025. Total expenditures rose sharply, contributing to a profit after tax of -4.72 Cr in March 2025.
When is the next results date for Salem Erode Inv.?
Salem Erode Inv. will declare its results on 13 November 2025.
Is Salem Erode Inv. overvalued or undervalued?
As of October 23, 2025, Salem Erode Inv. is considered a risky investment due to its overvaluation, indicated by a negative PE ratio of -10.70, an EV to EBITDA ratio of -50.98, and a year-to-date return of -22.29%, significantly underperforming compared to its peers and the Sensex.
Salem Erode Investments Ltd Declines 5.1% Today, Approaches 52-Week Low of Rs 36.56
Salem Erode Investments Ltd, a microcap in the NBFC sector, is experiencing notable buying activity despite a recent decline in stock performance. The stock has faced consecutive losses and is trading below key moving averages, while the broader market, represented by the Sensex, shows gains.
Is Salem Erode Inv. overvalued or undervalued?
As of October 17, 2025, Salem Erode Investment is considered overvalued with a PE ratio of -10.14 and significant financial distress, underperforming compared to peers and the Sensex.
Is Salem Erode Inv. overvalued or undervalued?
As of October 17, 2025, Salem Erode Inv. is considered overvalued with a valuation grade shift to expensive, reflected by a negative PE ratio of -10.14, an EV to EBITDA of -48.61, and a year-to-date stock return of -26.39%, significantly underperforming compared to peers and the Sensex.
Is Salem Erode Inv. overvalued or undervalued?
As of October 17, 2025, Salem Erode Inv. is considered overvalued with a PE ratio of -10.14 and an EV/EBITDA ratio of -48.61, significantly underperforming its peers and the Sensex, indicating a shift from risky to expensive.
Is Salem Erode Inv. overvalued or undervalued?
As of October 15, 2025, Salem Erode Inv. is considered overvalued and risky, with a negative PE ratio of -11.37 and an EV to EBITDA of -53.80, significantly underperforming its peers and the market.
Is Salem Erode Inv. overvalued or undervalued?
As of October 10, 2025, Salem Erode Investment is considered overvalued with a PE ratio of -10.44 and an EV to EBITDA of -49.88, significantly higher than its peers, and has underperformed the Sensex by 25.6% over the past year.
Is Salem Erode Inv. overvalued or undervalued?
As of October 10, 2025, Salem Erode Investment is considered overvalued with a negative PE ratio of -10.44 and an EV to EBITDA of -49.88, significantly worse than its peers, and has underperformed the Sensex with a year-to-date return of -24.2%.
Is Salem Erode Inv. overvalued or undervalued?
As of October 10, 2025, Salem Erode Investment is considered overvalued with a valuation grade shift from risky to expensive, reflected by a negative PE ratio of -10.44, an EV to EBITDA of -49.88, a ROE of -22.76%, and a year-to-date return of -24.2%, significantly underperforming compared to peers like Bajaj Finance and Life Insurance.
Is Salem Erode Inv. overvalued or undervalued?
As of September 19, 2025, Salem Erode Investment is considered risky and overvalued with a negative PE ratio of -10.56, an EV to EBITDA ratio of -50.36, and a -22.76% ROE, significantly underperforming compared to peers like Bajaj Finance and Life Insurance, and the Sensex.
Is Salem Erode Inv. overvalued or undervalued?
As of September 19, 2025, Salem Erode Inv. is considered overvalued with a valuation grade of risky, reflected by a PE ratio of -10.56, an EV to EBITDA of -50.36, and a year-to-date return of -23.37%, significantly underperforming compared to its peers and the Sensex.
Is Salem Erode Inv. overvalued or undervalued?
As of September 19, 2025, Salem Erode Inv. is considered overvalued and risky, with a negative PE ratio of -10.56, an EV to EBIT of -20.74, and a year-to-date return of -23.37%, significantly underperforming compared to peers like Bajaj Finance and Life Insurance.
Is Salem Erode Inv. overvalued or undervalued?
As of September 12, 2025, Salem Erode Investment is considered overvalued with a PE ratio of -10.70 and an EV to EBITDA of -50.96, significantly underperforming compared to peers like Bajaj Finance and Life Insurance, and has a year-to-date return of -22.33% versus the Sensex's 4.82%.
Is Salem Erode Inv. overvalued or undervalued?
As of September 12, 2025, Salem Erode Investment is considered overvalued with a negative PE ratio of -10.70 and an EV to EBITDA ratio of -50.96, significantly underperforming its peers and the market.
Is Salem Erode Inv. overvalued or undervalued?
As of September 12, 2025, Salem Erode Investment is considered overvalued with a PE ratio of -10.70 and an EV to EBITDA of -50.96, significantly underperforming its peers and the Sensex, indicating a shift in perception from risky to expensive.
Is Salem Erode Inv. overvalued or undervalued?
As of September 10, 2025, Salem Erode Investment is considered risky and overvalued due to its negative financial metrics, including a PE ratio of -10.40 and a year-to-date return of -24.5%, significantly underperforming compared to its peers and the Sensex.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
